MAPT and Alzheimer disease: Similar patterns were observed in AD biomarkers; MBI was linked to lower amyloid‐β 42/40 ratios and higher levels of phosphorylated and total tau, whereas transient NPS were only weakly associated with lower amyloid‐β 42/40 (Ismail, Leon, et al., 2023).